• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The diagnostic utility of immunophenotyping and immunogenotyping in the pathologic evaluation of lymphoid proliferations.

作者信息

Kamat D, Laszewski M J, Kemp J D, Goeken J A, Lutz C T, Platz C E, Dick F R

机构信息

Department of Pathology, University of Iowa, Iowa City.

出版信息

Mod Pathol. 1990 Mar;3(2):105-12.

PMID:2183210
Abstract

One hundred eighty-two specimens of suspected lymphoma and lymphocytic leukemia were examined by morphology, immunophenotype, and immunogenotype (genotype) in order to answer the following questions: How often and in what situations does immunophenotyping help resolve a diagnostic problem that is not resolved by morphology? How frequently does genotyping help resolve a diagnostic problem that is not resolved by morphology and immunophenotyping? Of 182 cases for which fresh tissue was available, sixty-five cases were considered morphological diagnostic problems: There were 32 cases of neoplasia versus non-neoplastic proliferation, 16 cases of neoplasia with undifferentiated or ambiguous morphology, and 17 cases of lymphoma or lymphocytic leukemia with an uncertain subtype. Immunophenotyping helped to resolve 33 of these 65 cases. Of the remaining 32 cases genotyping helped to resolve the diagnosis in 16. These results suggest that immunophenotyping may diagnose approximately 50% of those cases which present a morphological problem, and that genotyping is also helpful in a limited but significant number of problem cases.

摘要

相似文献

1
The diagnostic utility of immunophenotyping and immunogenotyping in the pathologic evaluation of lymphoid proliferations.
Mod Pathol. 1990 Mar;3(2):105-12.
2
[Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].112例淋巴系统恶性疾病的骨髓免疫表型分析
Ai Zheng. 2007 Apr;26(4):418-22.
3
A practical approach to the pathology of lymphoid neoplasms: a revised European-American classification from the International Lymphoma Study Group.淋巴瘤病理学的实用方法:国际淋巴瘤研究组修订的欧美分类。
Important Adv Oncol. 1995:111-40.
4
Lymphoid neoplasia in the koala.
Aust Vet J. 1998 Dec;76(12):819-25. doi: 10.1111/j.1751-0813.1998.tb12337.x.
5
[The value of multiparameter flow cytometry in diagnosis of lymphocytic leukemia and bone marrow involvement of non-Hodgkin's lymphoma].[多参数流式细胞术在淋巴细胞白血病诊断及非霍奇金淋巴瘤骨髓受累诊断中的价值]
Ai Zheng. 2003 Nov;22(11):1232-6.
6
T-cell receptor expression in lymphoid neoplasms. A comparison of phenotypic expression and genotyping.淋巴细胞肿瘤中的T细胞受体表达。表型表达与基因分型的比较。
Ann Clin Lab Sci. 1993 Nov-Dec;23(6):423-32.
7
Lymphoma 1987. An interim approach to diagnosis and classification.
Pathol Annu. 1987;22 Pt 2:1-67.
8
The role of flow cytometric immunophenotyping in improving the diagnostic accuracy in referred fine-needle aspiration specimens.流式细胞术免疫表型分析在提高送检细针穿刺标本诊断准确性方面的作用。
Diagn Cytopathol. 2004 Sep;31(3):159-63. doi: 10.1002/dc.20108.
9
Malignant lymphomas that mimic benign lymphoid lesions: a review of four lymphomas.酷似良性淋巴样病变的恶性淋巴瘤:四种淋巴瘤的综述
Semin Diagn Pathol. 1995 Feb;12(1):77-86.
10
[Immunochemical diagnosis of hepatic localizations in malignant lymphoid hematologic diseases. Study of 80 cases].[恶性淋巴血液系统疾病肝脏定位的免疫化学诊断。80例研究]
Gastroenterol Clin Biol. 1989 Apr;13(4):343-52.

引用本文的文献

1
Expression of the retinoblastoma protein is regulated in normal human tissues.视网膜母细胞瘤蛋白的表达在正常人体组织中受到调控。
Am J Pathol. 1994 Mar;144(3):500-10.
2
Comparison of the effects of Ficoll-Hypaque separation and whole blood lysis on results of immunophenotypic analysis of blood and bone marrow samples from patients with hematologic malignancies.Ficoll-Hypaque分离法与全血裂解对血液系统恶性肿瘤患者血液和骨髓样本免疫表型分析结果的影响比较。
Clin Diagn Lab Immunol. 1995 May;2(3):337-42. doi: 10.1128/cdli.2.3.337-342.1995.